SS Innovations International, Inc. (SSII): Cost of Revenue

Annual figures by period end, from SEC filings.

$22.94M
Year ended 2025-12-31
$27.43M
Trailing 12 months to 2026-06-30
+155.5%
3-year compound annual growth
2022-12-31: $1.38M2023-12-31: $5.15M2024-12-31: $12.20M2025-12-31: $22.94M$22.94M
2022-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$22.94M+88.1%2026-03-10, From 2025-01-01
2024-12-31$12.20M+136.8%2026-03-10, From 2024-01-01
2023-12-31$5.15M+274.4%2025-04-15, From 2023-01-01
2022-12-31$1.38Mn/a2024-12-20, From 2022-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
SS Innovations International, Inc. (SSII)2025-12-31$22.94M+88.1%
KORU Medical Systems, Inc. (KRMD)2025-12-31$15.52M+26.1%
SANUWAVE Health, Inc. (SNWV)2025-12-31$10.08M+24.7%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$6.96M+69.8%
Interpace Biosciences, Inc. (IDXG)2025-12-31$14.60M-14.1%
Utah Medical Products Inc (UTMD)2025-12-31$16.52M-1.4%
Retractable Technologies Inc (RVP)2025-12-31$38.22M+12.2%
Shoulder Innovations, Inc. (SI)2025-12-31$11.12M+52.6%
Cytosorbents Corp (CTSO)2025-12-31$10.57M-1.3%

Compare SSII, KRMD, SNWV, TLSI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗